{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:25:34Z","timestamp":1787739934675,"version":"build-2784847793"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA155258-10"],"award-info":[{"award-number":["CA155258-10"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX001584-09"],"award-info":[{"award-number":["BX001584-09"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["CA207237-05"],"award-info":[{"award-number":["CA207237-05"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018866","name":"Paula and Rodger Riney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003887","name":"International Myeloma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003887","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dana Farber\/Harvard Cancer Center SPORE in Multiple Myeloma","award":["SPORE-P50CA100707"],"award-info":[{"award-number":["SPORE-P50CA100707"]}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"crossref","award":["#29106"],"award-info":[{"award-number":["#29106"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FPRC \"5xmille\" 2021 Ministry of Health project"},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018857","name":"International Myeloma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"crossref","award":["#27750"],"award-info":[{"award-number":["#27750"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FPRC \"5xmille\" 2019 Ministry of Health project"},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"crossref","award":["IG24449"],"award-info":[{"award-number":["IG24449"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Weill Cornell Medicine (WCM) prostate cancer SPORE","award":["P50CA211024"],"award-info":[{"award-number":["P50CA211024"]}]},{"DOI":"10.13039\/100020424","name":"Weill Cornell Medicine","doi-asserted-by":"publisher","award":["T32CA260293"],"award-info":[{"award-number":["T32CA260293"]}],"id":[{"id":"10.13039\/100020424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["2022CHAL05"],"award-info":[{"award-number":["2022CHAL05"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0566"],"award-info":[{"award-number":["W81XWH-19-1-0566"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>In multiple myeloma, tumor cells reprogram metabolic pathways to sustain growth and monoclonal immunoglobulin production. This study examines acetyl-CoA carboxylase 1 (ACC1), the enzyme driving the rate-limiting step in de novo lipogenesis, in multiple myeloma metabolic reprogramming, particularly in c-MYC (MYC)\u2013driven subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Design:<\/jats:title>\n                    <jats:p>ACC1 expression was evaluated across multiple myeloma genetic subgroups, focusing on MYC translocations. Functional studies using ACC1 inhibitors and genetic knockdown assessed multiple myeloma cell growth, lipid synthesis, and metabolic homeostasis in vitro and in vivo. The role of MYC overexpression in ACC1 sensitivity was examined, with palmitate rescue experiments. Lipidomic analysis and assessments of endoplasmic reticulum (ER) stress, protein translation, and oxidative damage elucidated underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>ACC1 was overexpressed in MYC-translocated multiple myeloma. Its inhibition or knockdown reduced multiple myeloma cell growth in vitro and in vivo, particularly in MYC-overexpressing cells. ACC1 knockdown suppressed de novo lipid synthesis, partially rescued by palmitate. Lipidomic disruptions increased cholesterol ester desaturation and altered phospholipid ratios, inducing ER stress, impaired translation, protein carbonylation, oxidative damage, and apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>ACC1 is a metabolic vulnerability in MYC-driven multiple myeloma. Inhibiting ACC1 disrupts lipid homeostasis, induces ER stress, and causes oxidative damage, impairing cell survival. Targeting lipid synthesis pathways, especially in MYC-dependent subtypes, offers a promising therapeutic strategy for multiple myeloma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1078-0432.ccr-24-2000","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T14:31:11Z","timestamp":1741357871000},"page":"1975-1987","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeting Acetyl-CoA Carboxylase Suppresses\n                    <i>De Novo<\/i>\n                    Lipogenesis and Tumor Cell Growth in Multiple Myeloma"],"prefix":"10.1158","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8850-0442","authenticated-orcid":false,"given":"Eugenio","family":"Morelli","sequence":"first","affiliation":[{"name":"1Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy."},{"name":"2Department of Oncology, University of Torino, Candiolo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-6933","authenticated-orcid":false,"given":"Caroline Fidalgo","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7239-8324","authenticated-orcid":false,"given":"Silvia D.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3946-2898","authenticated-orcid":false,"given":"Claire","family":"Gao","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-8164","authenticated-orcid":false,"given":"Fabio","family":"Socciarelli","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-9320","authenticated-orcid":false,"given":"Domenico","family":"Maisano","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-7961","authenticated-orcid":false,"given":"Vanessa","family":"Favasuli","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6502-1109","authenticated-orcid":false,"given":"Na","family":"Liu","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-6871","authenticated-orcid":false,"given":"Katia","family":"Todoerti","sequence":"additional","affiliation":[{"name":"5Department of Diagnostic Innovation, IRCCS Istituto Nazionale dei Tumori, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5865-9593","authenticated-orcid":false,"given":"Chandraditya","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-6425","authenticated-orcid":false,"given":"Yao","family":"Yao","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."},{"name":"6Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1432-9742","authenticated-orcid":false,"given":"Mariateresa","family":"Fulciniti","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9978-5682","authenticated-orcid":false,"given":"Mehmet","family":"Samur","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0183-0562","authenticated-orcid":false,"given":"Anil","family":"Aktas-Samur","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1345-4410","authenticated-orcid":false,"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[{"name":"7Department of Clinical and Experimental Medicine, Magna Graecia University, Catanzaro, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-1794","authenticated-orcid":false,"given":"Marcello","family":"Turi","sequence":"additional","affiliation":[{"name":"1Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9295-4084","authenticated-orcid":false,"given":"Francesca","family":"Barello","sequence":"additional","affiliation":[{"name":"1Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6781-1823","authenticated-orcid":false,"given":"Johany","family":"Penailillo","sequence":"additional","affiliation":[{"name":"8Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-6088","authenticated-orcid":false,"given":"Cesarina","family":"Giallongo","sequence":"additional","affiliation":[{"name":"9Department of Medical, Surgical Sciences and Advanced Technologies \u201cG. F. Ingrassia\u201d, University of Catania, Catania, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-4433","authenticated-orcid":false,"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[{"name":"10Department of Surgery and Medical Specialties, University of Catania, Catania, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-0095","authenticated-orcid":false,"given":"Annamaria","family":"Gulla","sequence":"additional","affiliation":[{"name":"1Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-0886","authenticated-orcid":false,"given":"Kenneth C.","family":"Anderson","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0864","authenticated-orcid":false,"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7344-9795","authenticated-orcid":false,"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."},{"name":"11VA Boston Healthcare System, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-8379","authenticated-orcid":false,"given":"Massimo","family":"Loda","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York."},{"name":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts."},{"name":"12Nuffield Department of Surgical Sciences, Lincoln College, University of Oxford, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"2026051420312416700_bib1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"key":"2026051420312416700_bib2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2013viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"2026051420312416700_bib3","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","article-title":"Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry","volume":"4","author":"Sung","year":"2019","journal-title":"Lancet Public Health"},{"key":"2026051420312416700_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N Engl J Med"},{"key":"2026051420312416700_bib5","doi-asserted-by":"crossref","first-page":"34329","DOI":"10.18632\/oncotarget.6020","article-title":"Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"2026051420312416700_bib6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/222994a0","article-title":"Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane)","volume":"222","author":"Anderson","year":"1969","journal-title":"Nature"},{"key":"2026051420312416700_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41375-020-0962-2","article-title":"The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma","volume":"35","author":"Longo","year":"2021","journal-title":"Leukemia"},{"key":"2026051420312416700_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1631\/jzus.B0740640","article-title":"Increased fatty acid synthase as a potential therapeutic target in multiple myeloma","volume":"9","author":"Wang","year":"2008","journal-title":"J Zhejiang Univ Sci B"},{"key":"2026051420312416700_bib9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/labinvest.2008.97","article-title":"Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer","volume":"88","author":"Fiorentino","year":"2008","journal-title":"Lab Invest"},{"key":"2026051420312416700_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br J Cancer"},{"key":"2026051420312416700_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40170-020-00237-2","article-title":"The diversity and breadth of cancer cell fatty acid metabolism","volume":"9","author":"Nagarajan","year":"2021","journal-title":"Cancer Metab"},{"key":"2026051420312416700_bib12","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.84.14.5034","article-title":"Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma","volume":"84","author":"Staal","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026051420312416700_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature01611","article-title":"Wnt proteins are lipid-modified and can act as stem cell growth factors","volume":"423","author":"Willert","year":"2003","journal-title":"Nature"},{"key":"2026051420312416700_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.10127","article-title":"Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer","volume":"98","author":"Swinnen","year":"2002","journal-title":"Int J Cancer"},{"key":"2026051420312416700_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3","article-title":"Selective activation of the fatty acid synthesis pathway in human prostate cancer","volume":"88","author":"Swinnen","year":"2000","journal-title":"Int J Cancer"},{"key":"2026051420312416700_bib16","first-page":"201","article-title":"Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia","volume":"150","author":"Rashid","year":"1997","journal-title":"Am J Pathol"},{"key":"2026051420312416700_bib17","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1158\/1078-0432.CCR-07-5074","article-title":"Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells","volume":"14","author":"Zhan","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2026051420312416700_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12032-014-0391-z","article-title":"Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer","volume":"32","author":"Cai","year":"2015","journal-title":"Med Oncol"},{"key":"2026051420312416700_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K","article-title":"Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients","volume":"77","author":"Alo","year":"1996","journal-title":"Cancer"},{"key":"2026051420312416700_bib20","first-page":"2115","article-title":"Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma","volume":"3","author":"Milgraum","year":"1997","journal-title":"Clin Cancer Res"},{"key":"2026051420312416700_bib21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1158\/1535-7163.MCT-09-1061","article-title":"Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma","volume":"9","author":"Uddin","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"2026051420312416700_bib22","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.91.14.6379","article-title":"Fatty acid synthesis: a potential selective target for antineoplastic therapy","volume":"91","author":"Kuhajda","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026051420312416700_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0021-9258(18)64285-1","article-title":"Fatty acid synthesis in adipose tissue. I. Purification and properties of a long chain fatty acid-synthesizing system","volume":"236","author":"Martin","year":"1961","journal-title":"J Biol Chem"},{"key":"2026051420312416700_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.2022016892","article-title":"A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth","volume":"141","author":"Morelli","year":"2023","journal-title":"Blood"},{"key":"2026051420312416700_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood-2018-03-836601","article-title":"Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92","volume":"132","author":"Morelli","year":"2018","journal-title":"Blood"},{"key":"2026051420312416700_bib26","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"N Engl J Med"},{"key":"2026051420312416700_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"2026051420312416700_bib28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1073\/pnas.1808834116","article-title":"Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer","volume":"116","author":"Zadra","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026051420312416700_bib29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"2026051420312416700_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0891-5849(97)00104-4","article-title":"Protein carbonyl measurement by a sensitive ELISA method","volume":"23","author":"Buss","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"2026051420312416700_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cmet.2019.07.012","article-title":"The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth","volume":"30","author":"Gouw","year":"2019","journal-title":"Cell Metab"},{"key":"2026051420312416700_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nm.4181","article-title":"Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models","volume":"22","author":"Svensson","year":"2016","journal-title":"Nat Med"},{"key":"2026051420312416700_bib33","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats","volume":"113","author":"Harriman","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026051420312416700_bib34","doi-asserted-by":"crossref","first-page":"100797","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026051420312416700_bib35","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1101\/gad.13.10.1211","article-title":"Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls","volume":"13","author":"Kaufman","year":"1999","journal-title":"Genes Dev"},{"key":"2026051420312416700_bib36","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.yexcr.2009.06.009","article-title":"Activation of mammalian IRE1alpha upon ER stress depends on dissociation of BiP rather than on direct interaction with unfolded proteins","volume":"315","author":"Oikawa","year":"2009","journal-title":"Exp Cell Res"},{"key":"2026051420312416700_bib37","doi-asserted-by":"crossref","first-page":"e202402702","DOI":"10.26508\/lsa.202402702","article-title":"Chaperone BiP controls ER stress sensor Ire1 through interactions with its oligomers","volume":"7","author":"Dawes","year":"2024","journal-title":"Life Sci Alliance"},{"key":"2026051420312416700_bib38","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1186\/s12885-018-5178-8","article-title":"GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines","volume":"18","author":"Cultrara","year":"2018","journal-title":"BMC Cancer"},{"key":"2026051420312416700_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lfs.2019.04.022","article-title":"GRP78: a cell\u2019s response to stress","volume":"226","author":"Ibrahim","year":"2019","journal-title":"Life Sci"},{"key":"2026051420312416700_bib40","doi-asserted-by":"crossref","first-page":"e2303448120","DOI":"10.1073\/pnas.2303448120","article-title":"ER chaperone GRP78\/BiP translocates to the nucleus under stress and acts as a transcriptional regulator","volume":"120","author":"Liu","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026051420312416700_bib41","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.3390\/ijms22115574","article-title":"From metabolism to genetics and vice versa: the rising role of oncometabolites in cancer development and therapy","volume":"22","author":"Di Gregorio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026051420312416700_bib42","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1172\/JCI67228","article-title":"Oncometabolites: linking altered metabolism with cancer","volume":"123","author":"Yang","year":"2013","journal-title":"J Clin Invest"},{"key":"2026051420312416700_bib43","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2014.112","article-title":"PKA\/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells","volume":"28","author":"Medina","year":"2014","journal-title":"Leukemia"},{"key":"2026051420312416700_bib44","first-page":"171","article-title":"Adiponectin receptor agonist AdipoRon inhibits the proliferation of myeloma cells via the AMPK\/autophagy pathway","volume":"28","author":"Wang","year":"2020","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2026051420312416700_bib45","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1038\/s41467-019-12298-z","article-title":"High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program","volume":"10","author":"Labb\u00e9","year":"2019","journal-title":"Nat Commun"},{"key":"2026051420312416700_bib46","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1158\/0008-5472.CAN-14-1490","article-title":"AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer","volume":"74","author":"Priolo","year":"2014","journal-title":"Cancer Res"},{"key":"2026051420312416700_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention","volume":"159","author":"Butler","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"2026051420312416700_bib48","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/0008-5472.CAN-06-1794","article-title":"Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells","volume":"67","author":"Little","year":"2007","journal-title":"Cancer Res"},{"key":"2026051420312416700_bib49","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","article-title":"Bortezomib induces anti-multiple myeloma immune response mediated by cGAS\/STING pathway activation","volume":"2","author":"Gulla","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"2026051420312416700_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature09968","article-title":"Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity","volume":"473","author":"Fu","year":"2011","journal-title":"Nature"},{"key":"2026051420312416700_bib51","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.1217611110","article-title":"Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains","volume":"110","author":"Volmer","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026051420312416700_bib52","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molcel.2018.07.019","article-title":"Integrated functions of membrane property sensors and a hidden side of the unfolded protein response","volume":"71","author":"Covino","year":"2018","journal-title":"Mol Cell"},{"key":"2026051420312416700_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-4-32","article-title":"hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer","volume":"4","author":"Franklin","year":"2005","journal-title":"Mol Cancer"},{"key":"2026051420312416700_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","article-title":"Cholesterol levels in patients with multiple myeloma","volume":"87","author":"Yavasoglu","year":"2008","journal-title":"Ann Hematol"},{"key":"2026051420312416700_bib55","doi-asserted-by":"crossref","first-page":"928821","DOI":"10.3389\/fphar.2023.928821","article-title":"The role of cholesterol metabolism in tumor therapy, from bench to bed","volume":"14","author":"Xia","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026051420312416700_bib56","doi-asserted-by":"crossref","first-page":"622908","DOI":"10.3389\/fcell.2021.622908","article-title":"Role of cholesterol and lipid rafts in cancer signaling: a promising therapeutic opportunity?","volume":"9","author":"Vona","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026051420312416700_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12944-021-01593-8","article-title":"How cancer cells remodel lipid metabolism: strategies targeting transcription factors","volume":"20","author":"Jeong","year":"2021","journal-title":"Lipids Health Dis"},{"key":"2026051420312416700_bib58","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/s41467-020-19501-6","article-title":"FABP3-mediated membrane lipid saturation alters fluidity and induces ER stress in skeletal muscle with aging","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"2026051420312416700_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12185-016-2016-0","article-title":"Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma","volume":"104","author":"Ri","year":"2016","journal-title":"Int J Hematol"},{"key":"2026051420312416700_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1349-7006.2008.01038.x","article-title":"Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1","volume":"100","author":"Ri","year":"2009","journal-title":"Cancer Sci"},{"key":"2026051420312416700_bib61","doi-asserted-by":"crossref","first-page":"eadh1922","DOI":"10.1126\/scisignal.adh1922","article-title":"Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused by PARP inhibition","volume":"17","author":"Ribeiro","year":"2024","journal-title":"Sci Signal"},{"key":"2026051420312416700_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3324\/haematol.2019.240713","article-title":"Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma","volume":"106","author":"Caracciolo","year":"2021","journal-title":"Haematologica"},{"key":"2026051420312416700_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2022.01.001","article-title":"New avenues for NASH therapy by targeting ACC","volume":"34","author":"Bian","year":"2022","journal-title":"Cell Metab"},{"key":"2026051420312416700_bib64","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S2468-1253(24)00246-2","article-title":"Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Loomba","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026051420312416700_bib65","doi-asserted-by":"crossref","first-page":"e32357","DOI":"10.1097\/MD.0000000000032357","article-title":"Efficacy and safety of acetyl-CoA carboxylase (ACC) inhibitors in the treatment of nonalcoholic steatohepatitis (NASH): a protocol for systematic review","volume":"101","author":"Xu","year":"2022","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/doi\/10.1158\/1078-0432.CCR-24-2000\/3554054\/ccr-24-2000.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/doi\/10.1158\/1078-0432.CCR-24-2000\/3568961\/ccr-24-2000.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/31\/10\/1975\/3602974\/ccr-24-2000.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/31\/10\/1975\/3602974\/ccr-24-2000.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:31:40Z","timestamp":1778805100000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/31\/10\/1975\/762215\/Targeting-Acetyl-CoA-Carboxylase-Suppresses-De"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2025,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-24-2000","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1078-0432.29072317","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.29072326","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.29072314","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.29072323","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.29072320","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1078-0432.c.7819864","asserted-by":"object"}]},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}